Accumetrics
SAN DIEGO, December 7, 2010 - Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy-to-use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, closes 2010
with continued positive medical community and industry support surrounding
the importance of measuring response to antiplatelet therapy.
SAN DIEGO -
- Despite Difficult Markets, Cutting-Edge Medical Diagnostics Company Oversubscribes Its Fundraising Effort
Accumetrics, Inc., developer and marketer of the VerifyNow(R) System, the first rapid and easy-to-use diagnostic system for measuring an individual's response to multiple antiplatelet agents, announced today that it has completed a round of financing that will raise US$16.5 million in new capital.
SAN DIEGO -
Accumetrics, Inc.
SAN DIEGO, California -
With the recent FDA approval of the new P2Y12 inhibitor, prasugrel (Effient), Accumetrics, Inc.
SAN DIEGO - Accumetrics, Inc.
